Head and Neck Cancer IPD Meta-Analysis Protocols
Méta-Analyses et cancers ORL

• ASCO 2020 - Head and Neck cancer meta-analysis poster

Membres de l’équipe Epidémiologie des radiations, épidémiologie clinique des cancers et survie

• Directeur : Florent de Vathaire (DR1 INSERM)
• Assistante de gestion : Françoise Terrier
• Chef de projet : Karim Semar
• Onco-pédiatres : Odile Oberlin, Chiraz El-Fayech
• Endocrino-pédiatre : Cécile Thomas-Teinturier
• Chercheurs : Carole Rubino (CR1 INSERM), Nadia Haddy (CR1 INSERM)
• Post-doctorants : Rodrigue Sètchéou Allodji, Constance Xhaard

• Xhaard C, Ren Y, Clero E, Maillard S, Brindel P, Rachedi F, Boissin JL, Sebbag J, Shan L, Bost-Bezeaud F, Petitdidier P, Drozdovitch V, Doyon F, Rubino C, de Vathaire F. Differentiated thyroid carcinoma risk factors in French Polynesia. Asian Pac J Cancer Prev. 2014 http://www.ncbi.nlm.nih.gov/pubmed/24761883

Equipe Epidémiologie des radiations, épidémiologie clinique des cancers et survie

Cette équipe est rattachée à l’UMR 1018/CESP

L'équipe concentre ses travaux sur l'épidémiologie des cancers, et plus particulièrement sur l'épidémiologie des effets des rayonnements ionisants, des effets iatrogènes à long terme des traitements anticancéreux et sur le devenir des patients traités pour un cancer ou une tumeur.

Research Units at Gustave Roussy

Joint research units Inserm / Gustave Roussy / Université Paris-Saclay

• UMR 981 - Molecular predictors and new targets in oncology
• UMR 1015 - Immunology of tumors and cancer immunotherapy
• UMR 1030 - Molecular Radiotherapy and Novel Therapeutics

Gustave Roussy Research Platforms

Gustave Roussy has arranged that each of its research departments provides technical resources in common, the benefits of which are shared between all of its component research units. This mutual arrangement encourages interactions between departments and continuity within the research process. 

These platforms are brought together within the UMS AMMICa (CNRS UMS 3655 / Inserm US 23):

Lab members

• Leaders
  Isabelle PLO-AZEVEDO (DR2 INSERM), Hana RASLOVA (DR2 INSERM)
• Researchers
  Isabelle GODIN (DR2 CNRS), William VAINCHENKER (DRE INSERM), Najet DEBILI (DRE CNRS), Jean-Luc VILLEVAL (DRE INSERM), Monika WITTNER (CR1 CNRS), Antonio DI STEFANO (CRCN INSERM), Caroline MARTY (CRCN INSERM) ), Iléana ANTONY-DEBRE (CRCN INSERM)
• Clinicians / biologists
  Rémi FAVIER (PH APHP, Christine BELLANNE (MCU-PH / Interface INSERM), Florence PASQUIER (PH IGR), Christophe MARZAC (PH IGR), Jean-Baptiste MICOL (PH IGR)
• Technicians

Major publications

• Toppaldoddi KR, da Costa Cacemiro M, Bluteau O, Panneau-Schmaltz B, Pioch A, Muller D, Villeval JL, Raslova H, Constantinescu SN, Plo I, Vainchenker W, Marty C. Rare type 1-like and type 2-like calreticulin mutants induce similar myeloproliferative neoplasms as prevalent type 1 and 2 mutants in mice. Oncogene. 2019 Mar;38(10):1651-1660.

From haematopoietic stem cell to megakaryocyte

This group belongs to the UMR 1287: Hematopoietic stem cells and the development of hematological malignancies

Our research:

Bioinformatics core facility - Lab members

• Head of the bioinformatics core facility: Marc Deloger (marc.deloger@gustaveroussy.fr)

• "Core Service" bioinformaticians (permanent employees): Thibault Dayris, M’boyba Diop, Bastien Job, Gérôme Jules-Clement, Franck Le-Layo.

• "Core Service" bioinformaticians (non-permanent employees) : Marine Aglave, Edi Tihic